Exploring the Potential of Gold Nanoparticles in Proton Therapy: Mechanisms, Advances, and Clinical Horizons
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(2), P. 176 - 176
Published: Jan. 30, 2025
Proton
therapy
represents
a
groundbreaking
advancement
in
cancer
radiotherapy,
leveraging
the
unique
spatial
energy
distribution
of
protons
to
deliver
precise,
high-dose
radiation
tumors
while
sparing
surrounding
healthy
tissues.
Despite
its
clinical
success,
proton
faces
challenges
optimizing
therapeutic
precision
and
efficacy.
Recent
research
has
highlighted
potential
gold
nanoparticles
enhance
outcomes.
Due
their
high
atomic
number
favorable
biological
properties,
act
as
radiosensitizers
by
amplifying
generation
secondary
electrons
reactive
oxygen
species
upon
irradiation.
This
enhances
DNA
damage
tumor
cells
preserving
Additionally,
functionalization
with
tumor-targeting
ligands
offers
improved
precision,
making
more
effective
against
broader
range
cancers.
review
synthesizes
current
knowledge
on
mechanisms
nanoparticle
radiosensitization,
preclinical
evidence,
technological
hurdles
that
must
be
addressed
integrate
this
promising
approach
into
practice,
aiming
advance
efficacy
accessibility
therapy.
Language: Английский
The influence of atomic number on the radiosensitization efficiency of metallic nanorods: A Monte Carlo simulation study
Ali Taheri,
No information about this author
M.U. Khandaker,
No information about this author
Hans Rabus
No information about this author
et al.
Radiation Physics and Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 112589 - 112589
Published: Feb. 1, 2025
Language: Английский
Gold Nanoparticle-Enhanced Production of Reactive Oxygen Species for Radiotherapy and Phototherapy
Viet-Khang Nguyen,
No information about this author
Shiao‐Wen Tsai,
No information about this author
I-Chun Cho
No information about this author
et al.
Nanomaterials,
Journal Year:
2025,
Volume and Issue:
15(4), P. 317 - 317
Published: Feb. 19, 2025
Gold
nanoparticles
(GNPs)
have
gained
significant
attention
as
multifunctional
agents
in
biomedical
applications,
particularly
for
enhancing
radiotherapy.
Their
advantages,
including
low
toxicity,
high
biocompatibility,
and
excellent
conductivity,
make
them
promising
candidates
improving
treatment
outcomes
across
various
radiation
sources,
such
femtosecond
lasers,
X-rays,
Cs-137,
proton
beams.
However,
a
deeper
understanding
of
their
precise
mechanisms
radiotherapy
is
essential
maximizing
therapeutic
potential.
This
review
explores
the
role
GNPs
reactive
oxygen
species
(ROS)
generation
through
plasmon-induced
hot
electrons
or
radiation-induced
secondary
electrons,
leading
to
cellular
damage
organelles
mitochondria
cytoskeleton.
additional
pathway
enhances
efficacy,
offering
new
possibilities.
Furthermore,
we
discuss
emerging
trends
future
perspectives,
highlighting
innovative
strategies
integrating
into
comprehensive
provides
insights
mechanisms,
potential
clinical
impact
cancer
treatment.
Language: Английский
Polyacrylic Acid-Coated LaB6 Nanoparticles as Efficient Sensitizers for Binary Proton Therapy
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(4), P. 515 - 515
Published: April 15, 2025
Proton
beam
therapy
(PBT)
is
a
rapidly
advancing
modality
of
hadron
therapy.
The
primary
advantage
proton
lies
in
unique
depth-dose
distribution
characterized
by
the
Bragg
peak,
which
enables
highly
targeted
irradiation
area
limited
to
tumor,
while
minimizing
impact
on
healthy
tissues.
However,
broader
clinical
adoption
ion
both
economic
and
radiobiological
constraints.
One
possible
ways
increase
relative
biological
effectiveness
(RBE)
involves
use
radiosensitizers.
Background/Objectives:
In
this
work,
we
investigated
efficacy
using
colloidal
solutions
lanthanum
hexaboride
(LaB6)
nanoparticles
(NPs)
coated
with
polyacrylic
acid
(PAA)
as
sensitizers
antitumor
irradiation.
This
material
has
not
yet
been
studied
extensively
so
far,
despite
its
promising
physical
chemical
properties
several
reports
biocompatibility.
Methods:
LaB6
NPs
were
synthesized
femtosecond
pulsed
laser
ablation,
functionalized
PAA
characterized.
safety
was
evaluated
vitro
Live/Dead
assay
cell
cultures:
EMT6/P,
BT-474,
vivo
Balb/c
mice
after
intravenous
(i.v.)
administration.
binary
model
human
ductal
carcinoma
mammary
gland
BT-474
female
Nu/j
intratumoral
(i.t.)
administration
at
dose
2.0
mg/mouse
local
(fractional
exposure
31
Gy
+
15
Gy).
biodistribution
LaB6-PAA
animal
body
also
evaluated.
Results:
Significant
enhancement
cancer
death
following
demonstrated
lines.
Although
observed
comparatively
lower—likely
due
high
sensitivity
xenografts—both
monotherapy
treatment
well
tolerated.
Conclusions:
show
promise
efficient
capable
enhancing
therapy,
offering
potential
path
forward
for
improving
therapeutic
outcomes.
Language: Английский
Lysine and arginine methylation of transcription factors
Cellular and Molecular Life Sciences,
Journal Year:
2024,
Volume and Issue:
82(1)
Published: Dec. 16, 2024
Abstract
Post-translational
modifications
(PTMs)
are
implicated
in
many
biological
processes
including
receptor
activation,
signal
transduction,
transcriptional
regulation
and
protein
turnover.
Lysine’s
side
chain
is
particularly
notable,
as
it
can
undergo
methylation,
acetylation,
SUMOylation
ubiquitination.
Methylation
affects
not
only
lysine
but
also
arginine
residues,
both
of
which
epigenetic
regulation.
Beyond
histone-tails
substrates,
dynamic
methylation
transcription
factors
has
been
described.
The
focus
this
review
on
these
non-histone
substrates
providing
a
detailed
discussion
what
currently
known
about
hypoxia-inducible
factor
(HIF),
P53,
nuclear
receptors
(NRs)
RELA.
role
regulating
stability
function
by
acting
docking
sites
for
methyl-reader
proteins
via
their
crosstalk
with
other
PTMs
explored.
Language: Английский